Block, Siteadmin, SkipCaptcha, Upload, Automoderated users, delete, edit, move, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, protect, rollback, Administrators, template
295,417
edits
Changes
Jump to navigation
Jump to search
mLine 23:
Line 23: − +
no edit summary
Hydroxychlorquine reportedly "directly reduces the binding of antiphospholipid [[antibody]]–β2-glycoprotein I complexes to phospholipid bilayers":<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518879/</ref>
Hydroxychlorquine reportedly "directly reduces the binding of antiphospholipid [[antibody]]–β2-glycoprotein I complexes to phospholipid bilayers":<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518879/</ref>
{{quotebox [W]e have provided clear evidence that HCQ can dissociate aPL IgG–β2GPI complexes from phospholipid bilayers. Additional studies will be needed to further define the molecular mechanism(s) for this dissociation and its possible role in modifying the APS disease process.}}
{{quotebox|[W]e have provided clear evidence that HCQ can dissociate aPL IgG–β2GPI complexes from phospholipid bilayers. Additional studies will be needed to further define the molecular mechanism(s) for this dissociation and its possible role in modifying the APS disease process.}}
==See also==
==See also==